With biosimilar drug development on the rise, researchers explore efficacy

The article focuses on the first biosimilar monoclonal antibody to be approved in Europe, and appears in the current edition of Immunotherapy, an online, peer-reviewed title from the Future Medicine imprint of Future Science Group. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail